@ARTICLE{
author={Oh Jiwon,Drulovic Jelena S,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Cheng Ying-Fang,Harp Christopher,Sierzega Malgorzata,Clayton David,Ratchford John,Goodyear Alexandra,Bar-Or Amit},
year={2025},
title={Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={3},
pages={109-109},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,...,Drulovic Jelena S,...,(broj koautora 19)},
year={2025},
title={Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study},
journal={LANCET NEUROLOGY},
volume={24},
number={8},
pages={656-666},
document_type={Article},
} 

@ARTICLE{
author={Bar-Or Amit,Oh J,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Harp C,Sierzega M,Clayton David,Chen Y,Ratchford JN,Goodyear Alexandra,Drulovic Jelena S},
year={2025},
title={Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={31},
number={2_SUPPL},
pages={244-244},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,Oh Jiwon,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Thomas Piia,Sierzega Malgorzata,Clayton David,Cheng Ying Fang,Ratchford John,Goodyear Alexandra,Drulovic Jelena S},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bar-Or Amit,Dufek Michal,Budincevic Hrvoje,Drulovic Jelena S,Habek Mario,Hua Le,Weber Martin,Thomas Piia,Napieralski Julie,Clayton David,Kuruvilla Denison,Qi Qi,Xu Yan,Goodyear Alexandra,Oh Jiwon},
year={2023},
title={Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={29},
number={},
pages={1049-1050},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hua Le,Bar-Or Amit,Weber Martin,Habek Mario,Budincevic Hrvoje,Thomas Piia,Napieralski Julie,Ratchford John,Qi Qi,Sierzega M,Drulovic Jelena S},
year={2023},
title={Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 Trial},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={-},
document_type={Meeting Abstract},
}